United Kingdom · 
Who invested in Scripta Therapeutics?
Scripta Therapeutics's investors include Parkwalk, Apollo, Oxford Science Enterprises and AlbionVC.
United Kingdom · Seed startup
Who invested in Scripta Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2025, from 1 source
- Latest round
- Seed, $12MNov 2025
- Investors
- 4
The rounds
- Nov 2025
Founders and team
From Scripta Therapeutics's own website: 2 founders, 4 on the team.
Peter HamleyCEO and Founder
Prof. Noel BuckleyAcademic co-founder
- Andy WalkerVP of Bioinformatics
- Jerry HuangVP of Machine Learning
- John BlackwoodVP of Biology
- Raymond BarlowNon-Executive Director
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Scripta Therapeutics
How much has Scripta Therapeutics raised?
Scripta Therapeutics has raised $12M across 1 round since 2025.
When did Scripta Therapeutics last raise?
Scripta Therapeutics's most recent round was a Seed of $12M in Nov 2025.
What was Scripta Therapeutics's biggest round?
Its most recent round, $12M in Nov 2025, is also its largest on record.
Who backed Scripta Therapeutics first?
Scripta Therapeutics's first round on record, in Nov 2025, was backed by Parkwalk, Apollo and Oxford Science Enterprises and 1 others.
What stage is Scripta Therapeutics at?
Scripta Therapeutics's latest named round is a Seed, in Nov 2025.
Where is Scripta Therapeutics based?
Scripta Therapeutics is based in the United Kingdom.
Companies like Scripta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.